TAO Synergies Inc.
NASDAQ Global MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- TAO Synergies Inc. (NASDAQ: TAOX) operates as a digital asset treasury company focused exclusively on the Bittensor ecosystem; it acquires, holds, and stakes TAO, the native utility token of Bittensor, a decentralized blockchain network for machine learning and artificial intelligence; the company generates revenue through staking yields and pursues capital appreciation aligned with the growth of decentralized AI. Founded in 2012 and headquartered at 1185 Avenue of the Americas, 3rd Floor, New York, New York, TAO Synergies previously operated as Synaptogenix, Inc., a clinical-stage biopharmaceutical firm developing synaptogenic therapeutics such as Bryostatin-1 analogs for neurodegenerative diseases including Alzheimer's, Fragile X syndrome, traumatic brain injury, stroke, and autism spectrum disorders, before pivoting to its current cryptocurrency treasury strategy. The company targets investors seeking exposure to the convergence of cryptocurrency and AI, with operations centered in the United States and global exposure via the Bittensor network. In June 2025, TAO Synergies changed its name from Synaptogenix, Inc. to reflect its strategic shift; it launched its TAO acquisition program in June 2025 with an initial purchase funded by cash reserves and a partnership with BitGo for secure custody; by July 17, 2025, it acquired 29,899 TAO tokens for $10 million at an average price of $334 per token, becoming the largest publicly traded pure-play TAO holder; in August 2025, holdings increased to 42,111 TAO tokens with plans for further accumulation and active staking; by October 2025, TAO holdings exceeded 54,000 tokens amid rising interest in Bittensor; the company provides transparency via periodic press releases, SEC filings, and initiatives like The TAO Daily and The TAO Pod to educate on decentralized AI opportunities.
Contrasting Endonovo Therapeutics (OTCMKTS:ENDVD) & Synaptogenix (NASDAQ:TAOX)
Head to Head Comparison: Synaptogenix (NASDAQ:TAOX) versus Ceapro (OTCMKTS:CRPOF)
TAO Synergies and Yuma Asset Management to Host Livestream on X: Bittensor (TAO) and DeAI Innovation
TAO Synergies Announces Initial $750,000 Investment in Yuma Asset Management's Subnet Funds
TAO Synergies Raises Bittensor (TAO) Holdings to over 54,000 Tokens, Largest Publicly Traded Holder of Top Decentralized AI Cryptocurrency
TAO Synergies Announces $11 Million Private Placement
TAO Synergies Launches "The TAO Daily," the Premier Media Platform for All Things Bittensor (TAO)
TAO Synergies Digital Assets Advisor James Altucher Speaks at Google's Planet Scale Consumer AI Event
TAO Synergies Welcomes Top Bittensor (TAO) Leader as Advisor for AI-Focused Crypto Treasury Strategy